Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Rhythmic cues to help walking after spinal cord injury

Official title: Exploring the Effects of Rhythmic Auditory Stimulation on Gait in Motor Incomplete Spinal Cord Injury: A Pilot Study

Run by University of California, Davis · NCT07674927 · Data updated 2026-11-12

This pilot test will see if a wearable rhythm device (MedRhythms) can help adults with motor incomplete spinal cord injury walk more steadily and comfortably.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorUniversity of California, Davis
Academic / other
Locations1 site (Sacramento, California)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJune 30, 2026
Trial IDNCT07674927 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with non-progressive SCI (AIS C, D, or E) who can walk with at least contact guard assistance and can perceive music.

Probably not a fit

Individuals unable to attain a two-point walking pattern with an assistive device or who have other conditions limiting gait may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This small, early-stage study tests the feasibility and potential benefits of a wearable rhythmic auditory stimulation system for improving gait in people with non-progressive motor incomplete spinal cord injury. Participants will receive supervised gait training twice weekly for six weeks using the MedRhythms device, which delivers real-time, individualized rhythmic cues based on each person’s gait. Primary outcomes focus on walking speed, while secondary outcomes assess endurance, detailed gait parameters, and patient-reported quality of life related to social roles. The study uses standard gait assessments and self-reported measures to gauge preliminary efficacy and practicality of integrating the device into physical therapy.

Why it matters

Potential benefit: If successful, the approach could enhance walking ability and quality of life for some individuals with motor incomplete SCI.

How similar studies have gone: Preliminary studies in related gait rehabilitation approaches have shown promise, but this exact rhythmic auditory stimulation approach in motor incomplete SCI is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years old
* Language: English or Spanish only
* Diagnosis: non-progressive spinal cord lesion; classification as either grade C, D, or E SCI based on American Spinal Injury Association (ASIA) Impairment Scale (AIS)
* Able to ambulate at least a contact guard assist level
* Time post injury: ≥6 months
* Cadence: minimum 40 steps/minute with clear heel strike
* Able to consent

Exclusion Criteria:

* Individuals who use an assistive device and are unable to achieve a 2-point walking pattern (left-right-left-right) with an assistive device
* Walks exclusively with a 3-point walking pattern with an assistive device
* Ambulation requiring a knee-ankle-foot orthosis (KAFO)
* Presence of additional neurological or medical processes that contribute to weakness
* Unable to perceive music through the MedRhythyms device

Where it's running

  • UC Davis Point West
    Sacramento, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.